The Weekly Litigation News Digest is now live. Subscribe now

Composition For Treating Or Preventing Metabolic Disease, Containing, As Active Ingredient, Extracellular Vesicles Derived From Akkermansia Muciniphila Bacteria - EP3165227

The patent EP3165227 was granted to MD Healthcare on Oct 27, 2021. The application was originally filed on May 19, 2015 under application number EP15796520A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3165227

MD HEALTHCARE
Application Number
EP15796520A
Filing Date
May 19, 2015
Status
Patent Maintained As Amended
Sep 24, 2021
Publication Date
Oct 27, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ICOSA EUROPEDec 13, 2019WILLNEGGERADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTKR20100120846
INTERNATIONAL-SEARCH-REPORTKR20130021920
INTERNATIONAL-SEARCH-REPORTUS2013224155
OPPOSITIONKR20100120846
OPPOSITIONKR20130021920
OPPOSITIONUS2012222142
OPPOSITIONUS2013224155
OPPOSITIONWO2014019271
OPPOSITIONWO2014076246
SEARCHUS2012222142
SEARCHWO2014019271

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents